Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 1;208(11):1248.
doi: 10.1164/rccm.202308-1347LE.

Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension

Taro Yasuma  1 , Hajime Fujimoto  2 , Corina N D'Alessandro-Gabazza  1 , Esteban C Gabazza  1 , Osamu Hataji  3 , Tetsu Kobayashi  2
Affiliations

Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension

Taro Yasuma et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Yasuma et al.
    Norlander AE, Abney M, Cephus JY, Roe CE, Irish JM, Shelburne NJ, Newcomb DC, Hemnes AR, Peebles RS Jr. Norlander AE, et al. Am J Respir Crit Care Med. 2023 Dec 1;208(11):1249-1250. doi: 10.1164/rccm.202309-1622LE. Am J Respir Crit Care Med. 2023. PMID: 37774400 Free PMC article. No abstract available.

References

    1. Norlander AE, Abney M, Cephus JY, Roe CE, Irish JM, Shelburne NJ, et al. Prostaglandin I2 therapy promotes regulatory T cell generation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med . 2023;208:737–739. - PMC - PubMed
    1. Sitbon O, Vonk Noordegraaf A. Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience. Eur Respir Rev . 2017;26:160055. - PMC - PubMed
    1. Torres F, Rubin LJ. Treprostinil for the treatment of pulmonary arterial hypertension. Expert Rev Cardiovasc Ther . 2013;11:13–25. - PubMed
    1. Nathan SD. Progress in the treatment of pulmonary hypertension associated with interstitial lung disease. Am J Respir Crit Care Med . 2023;208:238–246. - PubMed

MeSH terms